乳果糖联合枯草杆菌、肠球菌二联活菌多维颗粒剂治疗新生儿黄疸的疗效

    Clinical efficacy observation of lactulose combined with live combined Bacillus subtilis and Enterococcus faecium granules with multivitamines in neonatal jaundice therapy

    • 摘要: 目的:观察乳果糖联合枯草杆菌、肠球菌二联活菌多维颗粒剂治疗新生儿黄疸的临床效果,并探讨其治疗机制。方法:将120例黄疸患儿随机均分为3组,对照组使用蓝光治疗,治疗A组在对照组的基础上加服枯草杆菌、肠球菌二联活菌多维颗粒剂0.15g,3次/天口服;治疗B组在治疗A组的基础上加服乳果糖口服液2ml,每天3次;3组均连续治疗6d,治疗后检测血中总胆红素水平。结果:治疗B组有效率明显高于对照组(P0.05);治疗A组与B组患儿经6d治疗后血中总胆红素水平均显著低于对照组(P0.01);治疗B组治疗后血中总胆红素水平低于治疗A组(P0.05)。结论:乳果糖联合枯草杆菌、肠球菌二联活菌多维颗粒剂可从两种不同的途径降低血中胆红素水平,治疗新生儿黄疸疗效确切,用药安全,值得临床推广使用。

       

      Abstract: Objective:To observe the clinical efficacy of lactulose combined with live combined Bacillus subtilis and Enterococcus faecium granules with multivitamines(Mamiai)in neonatal jaundice therapy and explore its therapeutic mechanism.Methods:One hundred and twenty cases of neonatal jaundice were randomly divided into three groups,blue-ray therapy was used in control group;in group A,Mamiai was added on the basis of the control group,and in group B,lactulose combined with Mamiai was added on the basis of the control group.Results:Compared with group A,the effective rate in group B was improved(P0.05).Compared with control group,neonatal blood total bilirubin content was significantly lower in group A and group B after 6 days treatment(P0.01).Compared with group A,neonatal blood total bilirubin content in group B was lower(P0.05).Conclusions:Lactulose combined with Mamiai reduces serum bilirubin level through two different mechanisms,the efficacy for treatment of neonatal jaundice was reliable,safe,and worthy of clinical use.

       

    /

    返回文章
    返回